ArticleAntioxidants (Basel, Switzerland)2020

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro.

Hyun Hwangbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.